INTRODUCTION AND OBJECTIVES:
We assessed the feasibility of robot-assisted partial nephrectomy (RAPN) in a contemporary series of patients with highly-complex tumors (PADUA score 10) treated at three high-volume robotic surgery institutions.
METHODS: Data from a multi-institutional database on patients subjected to RAPN for clinically-localized kidney cancer between 2010 and 2016 were reviewed. Overall, 198 patients with highly-complex renal tumors, defined as a PADUA score 10, were included. Complications, functional and oncological outcomes were assessed.
Optimal surgical outcomes, defined according to the Margin Ischemia and Complications (MIC) binary system (absence of Clavien-Dindo >2 complications, warm ischemia time [WIT] <20 minutes and absence of positive surgical margins) were assessed. Finally, predictors of optimal surgical outcomes were determined using logistic regression models (LRMs).
RESULTS: Median patient age was 61.5 years (IQR: 53-68), median preoperative tumor size was 43 mm (IQR 28-54), and median preoperative creatinine was 0.92 mg/dL (IQR: 0.80-1.13). Overall, 91 (46.0%) patients had a PADUA score 10, followed by 65 (32.8%) with a score of 11, 33 (16.7%) with a score of 12 and 9 (4.5%) with a score of 13. Median operative time was 180 minutes (IQR: 131-221), median WIT was 18 minutes (IQR: 15-22), and median estimated blood loss was 150 ml (IQR: 100-300). WIT was > 20 minutes in 62 (31.3%) patients, while a Clavien-Dindo >2 complication and positive surgical margins were observed in 12 patients (5.0%) and 4 (2.0%) individuals, respectively. Optimal surgical outcomes were achieved in 126 (63.6%) patients. Median creatinine the day after surgery was 1.10 mg/dL and remained stable 2 weeks later (median: 1.10 mg/dL. At a median followup of 22 months, no local or distant recurrence of the disease was observed. In multivariable LRMs, after adjustment for patient age, gender, BMI, side, CCI, and tumor size, extremely complex tumors (PADUA score 12-13) were associated with a 2.7 -fold higher risk of not achieving optimal outcomes (OR: 1.03-7.02; p¼0.044). In addition, males showed a 2.31-fold higher risk of not achieving optimal surgical outcomes (95%CI: 1.04-5.14; p¼0.040) relative to their female counterparts.
CONCLUSIONS: In experienced hands, RAPN can be considered as an effective treatment option even for complex renal lesions. Increasing tumor complexity may affect the surgical outcomes even in this highly-selected patient population.
Source of Funding: None

MP72-18 ONCOLOGICAL OUTCOMES OF POSITIVE SURGICAL MARGINS IN PATIENTS WHO UNDERWENT PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA.
Henrique Nonemacher*, Mauricio Cordeiro, George Lins de Albuquerque, Joao Brunhara, Paulo Afonso Carvalho, Fabio Gallucci, Leornardo Borges, Rafael Coelho, Sao Paulo, Brazil; Vipul Patel, Orlando, FL; Willian Nahas, Sao Paulo, Brazil INTRODUCTION AND OBJECTIVES: The prognostic significance and optimal management of positive surgical margins following partial nephrectomy remain controversial. The association between positive margin and risk of disease recurrence in patients with clinically localized renal neoplasm undergoing partial nephrectomy was evaluated.
METHODS: We analyzed the records of 429 patients cases of non-metastatic renal cell carcinoma who underwent partial nephrectomy (PN) at our institution, from 2001 to 2016. Recurrence-free survival was evaluated using Kaplan-Meier method, log rank test and Cox models adjusting for tumor size, grade, histology, pathological stage, focality and laterality. The relationship between positive margin and risk of relapse was evaluated independently for pathological high risk (Fuhrman grades III-IV) and low risk (Fuhrman grades I-II) groups.
RESULTS: A positive surgical margin was found in 55 (12.8%) patients. Recurrence developed in 26 (6%) patients during a median follow-up of 39 months. A positive margin was associated with an increased risk of relapse on multivariable analysis (HR 3.34, CI95%: 1.24 -8.10, p¼ 0.01) Graph 1. In a stratified analysis based on pathological features, a positive surgical margin was significantly associated with a higher risk of recurrence in cases of high risk (Fuhrmann III-IV) (HR 13.8, CI95%: 4.19 -45.9, p¼ 0.0005) Graph 2.
CONCLUSIONS: Positive surgical margins after partial nephrectomy increase the risk of disease recurrence, primarily in patients with high-risk pathological features. Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e961
Source INTRODUCTION AND OBJECTIVES: Laparoscopic Radical Nephrectomy (RN) is the current standard of care for large organ confined renal tumors while Partial Nephrectomy (PN) is recommanded for tumor sizes up to 7 cm. PN preserves long term renal function with possible effect on overall survival. Axitinib, a potent VEGFR TKI can reduce the size of primary tumor in metastatic setting. Our primary objective was to test the ability of axitinib to reduce the size of large tumors for shifting from a RN to a PN indication.
METHODS: Patients with localized (cT2N0M0) RCCs were enrolled in a prospective phase II trial assessing the effect of neoadjuvant axitinib prior to surgery (PN or RN). Main inclusion criteria were: age 18, histologically proven clear cell RCC, MDRD creatinin clearance 60 ml/min, cT2a N0NxM0 tumors (&[null]> 7cm; 10 cm). Medical treatment consisted in axitinib 5 mg up to 10 mg tw/d during 2 to 6 months prior surgery according to radiological response.
RESULTS: A total of 18 patients including 11 men (61%) and 7 women (39%) with a median age of 60 yrs were enrolled. Median baseline tumor size, RENAL score, serum creatinine and MDRD estimated GFR were: 7.6 cm, 11, 0.8 mg/dl and 96.5 ml/min respectively. Duration of treatment was 2, 4 and 6 months in 12 (66%), 3 (17%) and 3 cases (17%), respectively. Median interval from treatment stop to surgery was 6 days. After neoadjuvant treatment median tumor size and RENAL score decreased to 6.2 cm and 10. 89% of patients presented a decrease in maximum tumor diameter, with median size reduction of 19%. Out of the 17 patients who were operated, 16 (94%) underwent a PN (9 robotic & 7 open), including 67% of the cases which were performed for tumors 7cm. At 1 month from surgery, median serum creatinin and MDRD estimated GFR were 0.9 mg/dl and 87 ml/min, respectively. Medical and surgical complications included 1 embolization for severe bleeding and 1 Clavien V complication at 1 month after surgery due to massive myocardial infarction.
CONCLUSIONS: Neoadjuvant axitinib in cT2 renal tumors allowed cT1 downstaging and nephron sparing surgery in almost 70% of the cases. However, PN procedures remained high complexity cases requiring adequate surgeon expertise and information of the patients for possible morbidity of these procedures.
Source of Funding: none
MP72-20 DIFFERENTIAL HEMODYNAMIC AND ANTIHYPERTENSIVE CHANGES AFTER PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY
Ryan Hutchinson*, Nirmish Singla, Laura-Maria Krabbe, Solomon Woldu, Gong Chen, Charles Rew, Isamu Tachibana, Yair Lotan, Jeffrey A. Cadeddu, Vitaly Margulis, Dallas, TX INTRODUCTION AND OBJECTIVES: Partial nephrectomy is a common therapy for small renal masses and is associated with improved postoperative renal function when compared to radical nephrectomy. The highest quality prospective study of partial versus radical nephrectomy demonstrated worse overall survival in patients undergoing partial nephrectomy which appeared to be driven by cardiovascular outcomes. We examined patients undergoing partial and radical nephrectomy to assess for possible differential postsurgical hemodynamic effects.
METHODS: An institutional renal mass database was queried for patients undergoing partial or radical nephrectomy between 2006 and 2012. Serial blood pressure followup, clinicopathologic variables and changes in medications including antihypertensives were collected. Patients were excluded for inadequate data, non-curative-intent surgery, non-cancer surgical indication and absence of medication information. Time-dependent changes in blood pressure were compared by split-plot ANOVA and addition or modification of antihypertensive regimen were studied as time-to-event survival analyses with Kaplan-Meier curves and a Cox proportional hazards model. RESULTS: Between 2006 and 2012, 402 partial nephrectomies and 205 radical nephrectomies were performed and a final cohort of 264 partial nephrectomy and 130 radical nephrectomy cases was identified with evaluable data. Patients undergoing partial nephrectomy were significantly younger, more likely to have T1 tumors, and had lower preoperative creatinine values (p < 0.001 for all). No differences were noted on postoperative systolic blood pressures, diastolic blood pressures and heart rates (p > 0.05) however, these analyses were underpowered on post-hoc analysis. Significantly more patients who underwent partial nephrectomy started new antihypertensive medications postoperatively (p ¼ <0.001) and surgical treatment remained as a significant independent predictor on multivariate Cox regression (HR 2.51, p ¼ 0.002).
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